HomepageCVS • NYSE
add
CVS Health
$ 67,43
Na sluitingstijd:(0,27%)-0,18
$ 67,25
Gesloten: 3 jul, 14:31:04 GMT-4 · USD · NYSE · Disclaimer
Vorige slotkoers
$ 66,60
Dag-range
$ 66,63 - $ 67,78
Jaar-range
$ 43,56 - $ 72,51
Beurswaarde
85,30 mld. USD
Gem. volume
7,46 mln.
Koers/winst
16,11
Dividendrendement
3,94%
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 94,07 mld. | 6,92% |
Bedrijfskosten | 10,58 mld. | 4,48% |
Netto inkomsten | 1,78 mld. | 59,84% |
Netto winstmarge | 1,89 | 50,00% |
Winst per aandeel | 2,25 | 71,76% |
EBITDA | 4,45 mld. | 42,73% |
Effectief belastingtarief | 31,91% | — |
Balans
Totale activa
Totale passiva
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 12,65 mld. | -3,32% |
Totale activa | 255,58 mld. | 2,34% |
Totale passiva | 178,48 mld. | 1,64% |
Totaal aandelenvermogen | 77,11 mld. | — |
Uitstaande aandelen | 1,27 mld. | — |
Koers-boekwaardeverhouding | 1,09 | — |
Rendement op activa | 3,23% | — |
Rendement op kapitaal | 5,19% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 1,78 mld. | 59,84% |
Operationele kasstroom | 4,56 mld. | -7,08% |
Kasstroom uit beleggingen | -762,00 mln. | 63,61% |
Kasstroom uit financiering | -2,33 mld. | -90,06% |
Nettomutatie in liquide middelen | 1,46 mld. | -7,59% |
Vrije kasstroom | 3,49 mld. | -9,79% |
Over
CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. CVS and its subsidiaries have faced numerous controversies, including health and Medicare fraud, patient privacy violations, prescription errors, financial restatements, deceptive business practices, pharmaceutical kickbacks, and involvement in a political corruption case, resulting in hundreds of millions in settlements and widespread criticism. Wikipedia
CEO
Opgericht
1963
Hoofdvestiging
Website
Werknemers
259.500